MetLife (NYSE: MET) director defers 721-share stock award

Rhea-AI Filing Summary

MCKENZIE DIANA reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Diana McKenzie received a grant of 721 shares of common stock, valued at $71.17 per share, as part of non-management director retainer fees. Following this award, she directly holds 24,472 shares. She elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCKENZIE DIANA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$71.17	$51K

Holdings After Transaction: Common Stock — 24,472 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant size: 721 shares Grant valuation price: $71.17 per share Shares held after transaction: 24,472 shares

3 metrics

Stock grant size 721 shares Common stock award to director Diana McKenzie

Grant valuation price $71.17 per share Value used for the 721-share stock award

Shares held after transaction 24,472 shares Direct holdings following the grant

Key Terms

non-management director compensation arrangements, retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors

3 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion..."

retainer fees financial

"pay a portion of non-management director retainer fees in MetLife, Inc. common stock"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCKENZIE DIANA

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$71.17	24,472	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) director Diana McKenzie report?

Director Diana McKenzie reported receiving a grant of 721 shares of MetLife common stock as part of her non-management director retainer fees. This is a compensation-related award, not an open-market purchase, and increases her directly held position to 24,472 shares.

At what price was the MetLife (MET) stock award to Diana McKenzie valued?

The 721-share stock award to Diana McKenzie was valued at $71.17 per share. This per-share value is used for reporting the compensation grant and does not indicate that she bought shares on the open market at that price.

How many MetLife (MET) shares does Diana McKenzie now hold after this Form 4?

After the reported grant, Diana McKenzie holds 24,472 shares of MetLife common stock directly. This total reflects her position following the 721-share award reported in the Form 4 and shows her ongoing equity-based compensation as a non-management director.

Was the MetLife (MET) director stock grant an open-market purchase?

No, the transaction was coded as a grant or award, not an open-market purchase. The shares represent part of non-management director retainer fees paid in MetLife common stock, making this a compensation-related acquisition rather than a discretionary market trade.

Did Diana McKenzie defer her MetLife (MET) stock award under a plan?

Yes, she elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This means the granted shares are credited under that plan instead of being immediately delivered to her brokerage or personal account.

What does the Form 4 transaction code A mean for MetLife (MET)?

For this MetLife Form 4, transaction code A indicates a grant, award, or other acquisition of common stock. It reflects equity compensation given to director Diana McKenzie as part of her retainer, rather than a voluntary buy or sell in the open market.